|1.||Hisajima, Hiroshi: 1 article (12/2003)|
|2.||Matsuoka, Nobuya: 1 article (12/2003)|
|3.||Nakada, Hirohisa: 1 article (12/2003)|
|4.||Iwashita, Akinori: 1 article (12/2003)|
|5.||Maemoto, Takuya: 1 article (12/2003)|
|6.||Shima, Ichiro: 1 article (12/2003)|
|1.||Brain Ischemia (Cerebral Ischemia)
12/01/2003 - "In the present study, the neuroprotective efficacy of FR210575 was evaluated in two neuronal death models in vitro as well as rat focal cerebral ischemia models in vivo. "
12/01/2003 - "In two models of cerebral ischemia [photothrombotic occlusion of middle cerebral artery (MCA) for transient model and by permanent MCA occlusion for permanent model], rats received 3-h intravenous infusion (1-10 mg/kg/3 h) of FR210575, with brain damage determined 24 h later. "
|3.||Neurodegenerative Diseases (Neurodegenerative Disease)
|5.||Brain Injuries (Brain Injury)